Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia. Bone marrow transplantation

Mauricette Michallet, Peter Dreger, Mohamad Sobh, Linda Koster, Jennifer Hoek, Ariane Boumendil, Christof Scheid, Christopher P. Fox, Gerald Wulf, William Krüger, Michel van Gelder, Paolo Corradini, Domenico Russo, Jakob Passweg, Hélène Schoemans, Wolfgang Bethge, Nicolaas Schaap, Jan Cornelissen, Paul Browne, Nadira DurakovicLutz Muller, Silvia Montoto, Nicolaus Kroger, Johannes Schetelig

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia. Bone marrow transplantation'. Together they form a unique fingerprint.

Medicine & Life Sciences